Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | APEX1 | P27695 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | ESRRB | O95718 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL8512989 | 0.81 | ELANE (0.51) | ELANETDP1ALDH1A1 | |
| Benzene SCHEMBL28182923 | 0.81 | THRB (0.48) | POLBAPEX1HTTTDP1CHRM1 | |
| SCHEMBL824141 | 0.79 | ELANE (0.46) | ELANETDP1KDM4EALDH1A1 | |
| SCHEMBL19253941 | 0.79 | ELANE (0.44) | ELANEESR1POLBAPEX1HTT | |
| Benzil SCHEMBL10781939 | 0.79 | EGFR (0.50) | ELANEESR1POLBAPEX1HTT | |
| Benzoic Acid SCHEMBL31179841 | 0.79 | POLB (0.55) | ELANEESR1POLBAPEX1HTT | |
| SCHEMBL29089241 | 0.78 | ELANE (0.56) | ELANEPOLBAPEX1HTTTDP1 | |
| SCHEMBL6037217 | 0.78 | ALDH1A1 (0.50) | POLBAPEX1HTTTDP1CHRM1 | |
| SCHEMBL8084626 | 0.78 | CHRM1 (0.44) | POLBAPEX1HTTTDP1CHRM1 | |
| (Chloromethyl)Benzene SCHEMBL128111 | 0.76 | CHRM1 (0.49) | POLBAPEX1HTTTDP1CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10012902-B2 | Positive resist composition and pattern forming process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-07-03 | — | — | US | disclosed |
| US-20170242339-A1 | POSITIVE RESIST COMPOSITION AND PATTERN FORMING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10012902-B2 | Positive resist composition and pattern forming process | EWSR1, SRPRA, SRPRB | ELANE 2338/4885ESR1 510/4885POLB 182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.